Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Vaccine Contract Manufacturing Market, 2026 - The Overall Trend of Outsourcing Has Grown Significantly in the Biopharmaceuticals Industry - Research and Markets

This image opens in the lightbox

News provided by

Research and Markets

11 Jul, 2016, 14:24 GMT

Share this article

Share toX

Share this article

Share toX

DUBLIN, July 11, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Vaccine Contract Manufacturing Market, 2016 - 2026" report to their offering.

The "Vaccine Contract Manufacturing Market, 2016 - 2026" report provides an extensive study of the current market landscape of CMOs focused on vaccines. The study presents an in-depth analysis of a diverse set of biopharmaceutical CMOs based on key parameters such as geographical location, scale of operation, use of expression systems and manufacturing capabilities. In addition, it captures some of the potential growth areas that will likely present tremendous opportunities for vaccine CMOs and contribute to an accelerated pace of growth.

The report assesses the key drivers that have governed the evolution of vaccine contract manufacturing market over the past several years, along with an elaborate discussion on the future trends that are likely to shape the market in the coming years. One of the focus areas of this study is to estimate size of the future opportunity for vaccine CMOs market over the next decade, segmented on the basis of business operations, type of expression systems and key regions.

The study also provides information on some of the most important aspects of vaccine outsourcing; these include growing collaborations, investment activity, facility expansions and technological advances. In addition to some of the well-known benefits and a promising outlook, the study highlights considerable challenges that are currently prevalent in the market. Examples include quality concerns, stringent regulations and lack of funding. Nevertheless, these challenges are resulting in new strategies and technological improvements, which are likely to prove advantageous in the long run.

Example Highlights

- Vaccine development and manufacturing, characterized by complex production processes and high entry barriers, is set in a highly regulated market landscape. Outsourcing has emerged as a rising trend in this domain and gained a lot of traction in the last few years. As the market continues to evolve, CMOs are rapidly enhancing their service offering to offer end-to-end services to their clients.

- Developed regions, such as North America and Europe, currently dominate the vaccine contract manufacturing market. Of the 79 CMOs we identified, 41 have presence in multiple locations in the US. In Europe, the other major hub for CMOs, 20 CMOs have facilities located in Germany, France and the UK alone.

- CMOs in emerging locations have also gained ground. With increasing support from local governments, many low-income geographies have restructured their indigenous regulatory landscape. Intellectual property protection laws have been made more stringent in favor of foreign sponsors looking to outsource business operations in the same regions. Established players in this market have also received the necessary qualifications and certifications to provide services in compliance with global standards.

- Out of 79 CMOs, 21 offer end-to-end services across preclinical, clinical and commercial scale. We observed a rapid adoption of mammalian and insect production technologies among service providers.

- The highly competitive market landscape is abuzz with partnership activity. We have identified 128 unique partnerships that were inked in the recent past. Of these, a sizeable proportion (25%) is mergers / acquisitions. We believe this trend is likely to continue in the future.

- Technological advances are amongst the major driving factors in this market. The introduction of novel expression systems, such as the EB66® and GPEx® cell lines, and cell culture media platforms have sustained the interest of players in this field. Single use / disposable technologies, a key bio-manufacturing trend, are also becoming more and more popular among contract manufacturers. This is representative of the current market intensity.

- Driven by increasing global demand and the rapidly expanding vaccine market, we expect the overall contract manufacturing market in this space to grow at an annualized rate of 9.8%. The rate of growth is likely to vary significantly across different segments / activities and across geographical regions.

Key Topics Covered:

1. Preface

2. Executive Summary

3. Introduction

4. Competitive Landscape

5. Vaccine Contract Manufacturing: Developed Regions

6. Vaccine Contract Manufacturing: Emerging Regions

7. Recent Developments

8. Market Forecast

9. Swot Analysis

10. Future Trends

11. Conclusion

12. Interview Transcripts

13. Appendix I Tabulated Data

14. Appendix II List Of Companies And Organizations

Companies Mentioned

- 3P Biopharmaceuticals

- ABL

- Acambis

- Accugenix

- Actavis

- Advanced BioScience Laboratories

- Advaxis

- Aeras

- Air Force Hospital, Guangzhou

- AJ Biologics

- Albany Molecular Research (AMRI)

- Alexion

- Algonomics

- Altaris Capital Partner

- AmbioPharm

- AnaSpec

- Aptuit

- Association for Assessment and Accreditation of Laboratory Animal Care

- Association Sportive du Golf Club Val de l'Indre

- Australian Therapeutic Goods Administration

- Avid Bioservices

- Bachem

- Batavia Biosciences

- Bavarian Nordic

- Baxter BioPharma Solutions

- BD Biosciences

- Benchmark Vaccines

- Bharat Biotech

- Bill and Melinda Gates Foundation

- BioCell Corporation

- Biocon

- BioConnections

- BioConvergence

- Biofabri

- Bioline Group of Companies

- Biological E

- BioMARC

- Biomay

- Biomedical Advanced Research and Development Authority

- BioMotiv

- Biopharmaceutical Development Program - Frederick National Laboratory for Cancer Research

- BioReliance Holdings

- BioTechnique

- Biotechnology and Biological Sciences Research Council

- Biotechnology and Biological Sciences Research Council

- Biovest International

- Boehringer Ingelheim

- Boehringer Ingelheim BioXcellence

- Bristol-Myers Squibb

- Bryllan

- CALIXAR

- Canadian Animal Health Institute

- Canadian Council on Animal Care

- Catalent

- Catalent Pharma Solutions

- Celsis International

- Centers for Disease Control and Prevention

- CEPiA Sanofi (Transgene)

- Cetus Corporation

- CEVEC Pharmaceuticals

- Charles River Laboratories International

- Chimera Biotec

- China Agricultural University

- China National Biotec Group

- Chinese Center for Disease Control and Prevention

- Cobra Biologics

- Cook Pharmica

- Council of the Chinese University of Hong Kong

- Crucell Sweden

- Cytovance Biologics

- Daiichi Sankyo

- Deltamune

- Developing Countries Vaccine Manufacturers Network

- Dr. Reddy's Laboratories

- Emergent BioSolutions

- Engineering and Physical Sciences Research Council

- Eubiologics

- Eurogentec

- European Medicines Agency

- Federation of Indian Chambers of Commerce and Industry

- Florida Biologix

- Friedrich-Loeffler-Institut

- FUJIFILM Diosynth Biotechnologies

- Gallant Custom Laboratories

- Gamma Vaccines

- Genentech

- GENEWIZ

- GlaxoSmithKline

- Global Alliance for Vaccines and Immunizations

- GNH India

- Goodwin Biotechnology

- Government of India's Universal Immunisation Programme

- Grand River Aseptic Manufacturing

- GreenPak Biotech

- Guangxi Veterinary Research Institute

- Haffkine Institute

- HALIX

- Harbin Veterinary Research Institute

- Harbin Veterinary Research Institute, China

- HK Jockey Club Charities Trust

- HLL Biotech

- Hong Kong Institute of Biotechnology

- IDT Biologika

- Immune Design

- Immune Targeting Systems

- ImmunoSite Technologies

- ImVisioN Therapeutics

- Index Ventures

- Indian Council of Medical Research

- Indian Immunologicals

- Infectious Disease Research Institute

- Innovation & Technology Commission, HKSAR Government, China

- Integrity Bio

- Intercell

- International Medica Foundation

- International Society for Pharmaceutical Engineering

- Interros Group

- Inviragen

- Irvine Pharmaceutical Services

- Jubilant HollisterStier

- KABS Pharmaceutical Services

- Kaneka Corporation

- KBI Biopharma

- LigoCyte Pharmaceuticals

- Lonza

- Magellan Biosciences

- MassBiologics

- Medicago

- Mefar Ilac (Birgi Mefar Group)

- Meridian Life Science

- Ministry of Health & Family Welfare, Government of India

- Mitsubishi Gas Chemical Company

- Mitsubishi Tanabe Pharma Corporation

- Moderna Therapeutics

- Mymetics Corporation

- National Avian Influenza Reference Laboratory

- National Heart, Lung and Blood Institute

- National Institutes of Allergy and Infectious Diseases

- Norwegian Institute of Public Health

- Novartis

- Novasep

- Novavax

- NPO Petrovax Pharm

- NTC

- OctoPlus

- Okairos

- Oncotest

- Organization for Economic Cooperation and Development

- OSO Biopharmaceuticals Manufacturing (OsoBio)

- Pacific GMP

- Panacea Biotec

- Paragon Bioservices

- PATH

- Pfenex

- Pfizer

- Pfizer CentreOne

- Pharmapak

- PharmaSynth

- Premas Biotech

- Prime European Therapeuticals

- ProBioGen

- Protagen

- PX'Therapeutics

- QuiaPEG

- RAFAGEN

- Recipharm

- Richter-Helm

- Riemser Pharma

- SAFC

- Sanofi

- Sanofi Pasteur

- Sartorius Stedim Biotech

- Serum Institute

- Shandong Zhaoxin Bio-tech Company

- Shanghai Laboratory Animal Commission

- ShangPharma

- Sigma-Aldrich

- South China Agricultural University

- Statens Serum Institut

- Stellar Biotechnologies

- Swiss State Secretariat Education, Research and Innovation

- SynCo Bio Partners

- Technology Strategy Board

- Temasek Life Sciences Ventures

- The College of Animal Science and Technology, Sichuan Agricultural University, China

- Thermo Fisher Scientific

- Tianjin CanSino Biotechnology

- UK Medicines Control Agency

- Unitech Pharma Group

- United States Food and Drug Association

- Univercells

- University of Maryland

- University of Oxford

- University of Pennsylvania

- Upperton

- Vaccibody

- Vacsera

- Valneva

- Vetter Pharma International

- VGXI

- Vibalogics

- Vivalis

- Vybion (Recombinant Protein Technologies and Products)

- Waisman Biomanufacturing

- Walter Reed Army Institute of Research - Pilot Bioproduction Facility

- Wellcome Trust

- WIL Research

- World Trade Organization

- WuXi AppTec

- Zoetis

For more information visit http://www.researchandmarkets.com/research/v7vcc2/vaccine_contract

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.